Literature DB >> 9121264

Familial non-VHL non-papillary clear-cell renal cancer.

B T Teh, S Giraud, N F Sari, S I Hii, J P Bergerat, C Larsson, J M Limacher, D Nicol.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9121264     DOI： 10.1016/S0140-6736(05)61751-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

2.  Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.

Authors:  H Kanayama ; W O Lui; M Takahashi; T Naroda; D Kedra; F K Wong; Y Kuroki; Y Nakahori; C Larsson; S Kagawa; B T Teh
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

Review 3.  Familial adult renal neoplasia.

Authors:  M Takahashi; R Kahnoski; D Gross; D Nicol; B T Teh
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

4.  Inherited susceptibility to uterine leiomyomas and renal cell cancer.

Authors:  V Launonen; O Vierimaa; M Kiuru; J Isola; S Roth; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.

Authors:  E R Woodward; S C Clifford; D Astuti; N A Affara; E R Maher
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

6.  The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.

Authors:  K Dreijerink; E Braga; I Kuzmin; L Geil; F M Duh; D Angeloni; B Zbar; M I Lerman; E J Stanbridge; J D Minna; A Protopopov; J Li; V Kashuba; G Klein; E R Zabarovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

7.  Structured assessment and followup for patients with hereditary kidney tumour syndromes.

Authors:  Jean-Baptiste Lattouf; Stephen E Pautler; M Neil Reaume; Raymond H Kim; Melanie Care; Jane Green; Alan So; Philippe D Violette; Issam Saliba; Philippe Major; Shane Silver; Richard Leicht; Joan Basiuk; Simon Tanguay; Michael A S Jewett; Darrel Drachenberg
Journal:  Can Urol Assoc J       Date:  2016-07-12       Impact factor: 1.862

8.  Racial Disparities and Preventive Measures to Renal Cell Carcinoma.

Authors:  Jennifer N Sims; Clement G Yedjou; Daniel Abugri; Marinelle Payton; Timothy Turner; Lucio Miele; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2018-05-28       Impact factor: 3.390

9.  Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma.

Authors:  Christopher Ricketts; Maurice P Zeegers; Jan Lubinski; Eamonn R Maher
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.